Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

[A prospective study of adenosine triphosphate-tumor chemosensitivity assay directed chemotherapy in patients with recurrent ovarian cancer].

Gao YT, Wu LY, Zhang W, Zhao D, Li N, Tian HM, Wang XB, Li M, Sun YC, Li N, Li XG.

Zhonghua Fu Chan Ke Za Zhi. 2013 May;48(5):358-63. Chinese.

PMID:
24016479
[PubMed - indexed for MEDLINE]
2.

A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.

Cree IA, Kurbacher CM, Lamont A, Hindley AC, Love S; TCA Ovarian Cancer Trial Group.

Anticancer Drugs. 2007 Oct;18(9):1093-101.

PMID:
17704660
[PubMed - indexed for MEDLINE]
3.

[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer].

Zhao D, Wu LY, Li XG, Wang XB, Li M, Li YF, Tian HM, Song PP, Liu J, Chang QY, Zhang W.

Zhonghua Zhong Liu Za Zhi. 2010 Nov;32(11):855-8. Chinese.

PMID:
21223693
[PubMed - indexed for MEDLINE]
4.

Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer.

Kurbacher CM, Cree IA, Bruckner HW, Brenne U, Kurbacher JA, Müller K, Ackermann T, Gilster TJ, Wilhelm LM, Engel H, Mallmann PK, Andreotti PE.

Anticancer Drugs. 1998 Jan;9(1):51-7.

PMID:
9491792
[PubMed - indexed for MEDLINE]
5.

[Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].

Zhao D, Zhang W, Li XG, Wang XB, Zhang LF, Li M, Li YF, Tian HM, Song PP, Liu J, Chang QY, Wu LY.

Zhonghua Fu Chan Ke Za Zhi. 2011 Mar;46(3):193-8. Chinese.

PMID:
21575453
[PubMed - indexed for MEDLINE]
6.

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.

Sharma S, Neale MH, Di Nicolantonio F, Knight LA, Whitehouse PA, Mercer SJ, Higgins BR, Lamont A, Osborne R, Hindley AC, Kurbacher CM, Cree IA.

BMC Cancer. 2003 Jul 3;3:19.

PMID:
12841853
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.

Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M.

Gynecol Oncol. 2000 May;77(2):258-63.

PMID:
10785475
[PubMed - indexed for MEDLINE]
8.

Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer.

Neubauer H, Stefanova M, Solomayer E, Meisner C, Zwirner M, Wallwiener D, Fehm T.

Anticancer Res. 2008 Mar-Apr;28(2A):949-55.

PMID:
18507041
[PubMed - indexed for MEDLINE]
Free Article
9.

[Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].

Wu LY, Zhang R, Huang MN, Li N, Wang GX, Liu LY.

Ai Zheng. 2003 Apr;22(4):424-7. Chinese.

PMID:
12704005
[PubMed - indexed for MEDLINE]
10.

Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).

Khemapech N, Oranratanaphan S, Termrungruanglert W, Lertkhachonsuk R, Vasurattana A.

Asian Pac J Cancer Prev. 2013;14(3):2131-5.

PMID:
23679331
[PubMed - indexed for MEDLINE]
Free Article
11.

Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.

Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Blumenson LE.

Gynecol Oncol. 1998 Nov;71(2):190-5.

PMID:
9826459
[PubMed - indexed for MEDLINE]
12.

[Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].

Tian HM, Shi XY, Fu J, Chao DY, Zhang K, Wu LY, Wang JW, Zhang W.

Zhonghua Zhong Liu Za Zhi. 2005 May;27(5):296-8. Chinese.

PMID:
15996325
[PubMed - indexed for MEDLINE]
13.

[Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].

Mu T, Li XP, Wang JL, Wang SJ, Wang Y, Sun XL, Cui H, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):566-70. Chinese.

PMID:
23141174
[PubMed - indexed for MEDLINE]
14.

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.

Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I.

J Clin Oncol. 2014 May 1;32(13):1302-8. doi: 10.1200/JCO.2013.51.4489. Epub 2014 Mar 17.

PMID:
24637997
[PubMed - indexed for MEDLINE]
15.

Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.

O'Meara AT, Sevin BU.

Gynecol Oncol. 2001 Nov;83(2):334-42.

PMID:
11606094
[PubMed - indexed for MEDLINE]
16.

[Application of adenosine triphosphate tumor chemosensitive assay system to individual chemotherapy for hepatocellular carcinoma].

Chen T, Chu ZH, Liu JP, Wang J, Zhao HY, Ou QJ.

Ai Zheng. 2005 Aug;24(8):1018-22. Chinese.

PMID:
16086886
[PubMed - indexed for MEDLINE]
17.

Chemotherapy in recurrent epithelial ovarian cancer (EOC): an analysis of prognostic factors.

Shamsunder S, Kumar L, Gupta S, Kumar S, Bhatla N, Singh R, Kochupillai V.

J Obstet Gynaecol Res. 2000 Jun;26(3):215-22.

PMID:
10932985
[PubMed - indexed for MEDLINE]
18.

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.

Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ, Fruehauf JP.

Gynecol Oncol. 2002 Oct;87(1):8-16.

PMID:
12468336
[PubMed - indexed for MEDLINE]
19.

[Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer].

Yan X, An N, Jiang GQ, Gao M, Gao YN.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):298-301. Chinese.

PMID:
18788637
[PubMed - indexed for MEDLINE]
20.

ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.

Kurbacher CM, Grecu OM, Stier U, Gilster TJ, Janát MM, Untch M, Konecny G, Bruckner HW, Cree IA.

Recent Results Cancer Res. 2003;161:221-30. Review.

PMID:
12528810
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk